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Gap junctions are comprised of connexins that form cell-to-cell channels which couple
neighboring cells to accommodate the exchange of information. The need for commu-
nication does, however, change over time and therefore must be tightly controlled.
Although the regulation of connexin protein expression by transcription and translation
is of great importance, the trafﬁcking, channel activity and degradation are also under
tight control. The function of connexins can be regulated by several post translational
modiﬁcations, which affect numerous parameters; including number of channels, open
probability, single channel conductance or selectivity. The most extensively investigated
post translational modiﬁcations are phosphorylations, which have been documented in
all mammalian connexins. Besides phosphorylations, some connexins are known to
be ubiquitinated, SUMOylated, nitrosylated, hydroxylated, acetylated, methylated, and
γ-carboxyglutamated.The aim of the present review is to summarize our current knowledge
of post translational regulation of the connexin family of proteins.
Keywords: connexin, post translational modification, phosphorylation, sumoylation, nitrosylation, methylation,
acetylation, ubiquitination
INTRODUCTION
Connexins are a family of membrane proteins forming gap junc-
tional channels. Each connexin is a four membrane spanning
protein with two extracellular loops, an intracellular loop and
intracellular N- and C-termini (see Figure 1). Six connexins
oligomerize to form a connexon, which, once inserted in the
plasma membrane, may dock with a connexon from a neighbor-
ing cell and form an intercellular gap junctional channel. When
many intercellular channels aggregate, they form a gap junction
plaque, which present a typical penta-laminar structure when
viewed in transmission electron microscope images (Figure 1,
right panel). In some cases, free connexons may open directly to
the extracellular medium in which case they are often referred to
as hemichannels. This review will primarily deal with intercellular
gap junctional channels.
Gap junctions are responsible for direct intercellular commu-
nication in vertebrates and the connexin family has 21 members
in humans and 20 in mice (Willecke et al., 2002). The connex-
ins are named after their approximate molecular weight (e.g.,
Cx43 is a protein of app. 43 kDa), whereas the genes encoding
them are named GJX followed by a number with X indicat-
ing group (α, β, γ, δ or ε) based on homology and length of
their cytoplasmic loop (for more information about nomencla-
ture, see Nielsen et al., 2012). A list of gene and protein names for
human and mouse connexins is given in Table 1. In the present
review, we use the name of the human ortholog in general but
may also state species dependent names where relevant to avoid
confusion.
Gap junctions are instrumental in many physiological phe-
nomena, from embryonic development to propagation of cardiac
action potentials. Giving the diversity of these tasks, it is not
surprising that the connexins, which form the gap junctional
channels, come in many isoforms. By the expression of differ-
ent connexins, cells can regulate coupling in a tissue and time
dependent manner.
The connexin isoforms differ in their permeability to larger
molecules, termed metabolic coupling; and current in the form of
atomic ions, termed electrical coupling. Although it is often stated
that gap junctional channels are permeable to substances up to
1 kDa, metabolic coupling is highly variable among isoforms and
permeability is often unpredictable with respect to permeant size
and charge. Most of our current knowledge on metabolic coupling
comes from studies of ﬂuorescent tracer molecules and some cau-
tion is needed when comparing studies using different tracers, also
it should be kept in mind that permeability to biologically relevant
molecules cannot necessarily be inferred from tracer permeability.
More information about permeability of connexin channels can be
found in (Harris and Locke, 2009; Nielsen et al., 2012). Electrical
coupling can be measured by dual patch clamp and investigated as
either the total conductance between cells in a pair, termed macro-
scopic coupling, or single channel conductance, which is usually
determined under partial uncoupling by agents like octanol.
The characteristics of the various connexin isoforms enable
them to fulﬁll different physiological roles that may be more or less
connexin speciﬁc. In the case of the development of cardiac mor-
phology, Cx43 may be exchanged with Cx40 without consequence
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FIGURE 1 | Connexin structure. Gap junctional channels are comprised
of connexins, which have four transmembrane domains (TM1-4), two
extracellular loops (E1-2), a cytoplasmic loop (CL), N-terminus (NT) and
C-terminus (CT; upper left panel). Six connexins oligomerize and form
connexons (upper middle panel), which are transported to the
plasmamembrane. Here they dock with a connexon from a neighboring
cell and form full intercellular gap junctional channels (lower left panel),
that upon opening mediate exchange of ions and small metabolites. When
many channels aggregate, they form a gap junctional plaque, which can be
seen as a pentalaminar structure in the transmission electron microscope.
A plaque between two rat ventricular myocytes can be seen between the
arrows in the right panel of the ﬁgure (scale bar 100 nm). The image was
obtained in collaboration with Klaus Qvortrup, Core Facility for Integrated
Microscopy, University of Copenhagen.
and is thus relatively unspeciﬁc; however, the same exchange ren-
ders homozygous females unable to wean their pups and males
infertile, which shows that these processes are high dependent on
the speciﬁc properties of Cx43 (Plum et al., 2000).
Despite the possibility of altering intercellular coupling by
changing the connexin expression proﬁle, cells often need to
regulate communication acutely by altering the function and local-
ization of the connexins at hand. This is often mediated by post
translational modiﬁcations (PTMs). The most widely investigated
PTMs in connexins are phosphorylations and ubiquitinations, but
in recent years studies have shown how other PTM such as ubiqui-
tination, SUMOylation, nitrosylation, hydroxylation, acetylation,
methylation, and γ-carboxyglutamation also play important roles
in the regulation of intercellular communication.
Intercellular coupling is determined by both the number of
channels incorporated in gap junctions, their activity and selec-
tivity. The number of channels is regulated by transcription,
translation, oligomerization, trafﬁcking to and from the mem-
brane, and degradation. Pre-translational events (transcription
and translation) does of course not involve PTM (for review of
these processes in connexins, see Nielsen et al., 2012), but PTMs
are involved in the regulation of all other aspects of the connexin
lifecycle. The activity of gap junctional channels is determined by
their open probability, conductance and selectivity, each of which
can be regulated by PTMs. In the following, wewill review the state
of knowledge of how various PTMs regulate connexin function.
PHOSPHORYLATION – A KEY PLAYER IN THE REGULATION
OF GAP JUNCTIONS
The covalent binding of phosphate groups to either serine,
threonine or tyrosine residues of proteins is termed protein
phosphorylation. The addition of a phosphate group to a pro-
tein is facilitated by various protein kinases, whereas removal
of a phosphate group, dephosphorylation, is mediated by pro-
tein phosphatases. Protein phosphorylation was ﬁrst described by
Edmond Fischer and Edwin Krebs, who were awarded the Nobel
Prize for “their discoveries concerning reversible protein phospho-
rylation as a biological regulatory mechanism” in 1992. Today,
phosphorylation and dephosphorylation is well described and
potentially the most common way of controlling the activity and
function of proteins in biological systems. Following translation
of a protein, the phosphorylation state of the protein usually
determine the three-dimensional folding and conformation, the
intracellular trafﬁcking and activity of the protein, as well as its
interaction with other proteins. Phosphorylation of proteins is
therefore a key player in the regulation of all forms of cellular
processes.
The ﬁrst evidence that connexins are phosphoproteins was
published in the 1980s (Saez et al., 1986; Takeda et al., 1987).
Since then, tremendous amounts of work have contributed
to our current knowledge of site-speciﬁc phosphorylation and
dephosphorylation and its contribution to the post-translational
regulation of connexins. All the connexin family members are
now known to be phosphoproteins and connexin phosphoryla-
tion/dephosphorylation is involved in all stages of the connexin
life-cycle, the regulation of electrical and metabolic coupling of
gap junction channels, as well as regulation of connexin interac-
tionwith other proteins. The phosphorylation state of connexins is
dependent on interplay between various kinases andphosphatases,
it is often cell- or tissue-type speciﬁc and it is further affected by
various physiological and pathological conditions. This part of the
review aims at summarizing the current knowledge of connexin
phosphorylation, while highlighting the contradictions that exist
and turning attention to the areas, which need further elucidation.
PHOSPHORYLATION OF CONNEXIN43
Of the 21 identiﬁed members of the connexin family, the 43 kDa
subtype, connexin 43 (Cx43) is not only the most widely expressed
in mammalian cells, it is also the most intensively studied con-
nexin. Cx43 is translated as a 40 kDa protein, which becomes
phosphorylated to a 41 kDa form soon after synthesis (Puranam
et al., 1993). The early phosphorylation of Cx43, which results in
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Table 1 | Nomenclature of human and mouse connexin genes and
proteins.
Human Gene
name
Human
Protein name
Mouse gene
name
Mouse
protein name
GJE1 hCx23 Gje1 mCx23
GJB7 hCx25 No mouse
ortholog
No mouse
ortholog
GJB2 hCx26 Gjb2 mCx26
GJC3 hCx30.2 Gjc3 mCx29
GJB6 hCx30 Gjb6 mCx30
GJB4 hCx30.3 Gjb4 mCx30.3
GJB3 hCx31 Gjb3 mCx31
GJB5 hCx31.1 Gjb5 mCx31.1
GJD3 hCx31.9 Gjd3 mCx30.2
GJB1 hCx32 Gjb1 mCx32
No human
ortholog
No human
ortholog
Gja6 mCx33
GJD2 hCx36 Gjd2 mCx36
GJA4 hCx37 Gja4 mCx37
GJA5 hCx40 Gja5 mCx40
GJD4 hCx40.1 Gjd4 mCx39
GJA1 hCx43 Gja1 mCx43
GJC1 hCx45 Gjc1 mCx45
GJA3 hCx46 Gja3 mCx46
GJC2 hCx47 Gjc2 mCx47
GJA8 hCx50 Gja8 mCx50
GJA9* hCx59 No mouse
ortholog
No mouse
ortholog
GJA10 hCx62 Gja10 mCx57
*Previously named GJA10
the 41 kDa form, occurs in the ER or cis-medial Golgi (Puranam
et al., 1993). A more extensive phosphorylation, however, takes
place later in the secretory pathway or following formation of gap
junction channels at the plasma membrane. Today, 21 phospho-
rylation sites are described for Cx43 and a substantial amount of
experimental work have demonstrated that all stages of the Cx43
“life cycle” are modiﬁed by post-translational phosphorylation of
Cx43. In addition, pathophysiological conditions, such as ischemia
(Beardslee et al., 2000; Axelsen et al., 2006), hemodynamic volume
overload (Rucker-Martin et al., 2006; Qu et al., 2009) and diabetes
(Lin et al., 2006;Howarth et al., 2008),may affectCx43phosphory-
lation and thereby gap junction coupling betweenCx43 expressing
cells.
SITE SPECIFIC CX43 PHOSPHORYLATION AND THE RESPONSIBLE
PROTEIN KINASES
Figure 2 illustrates all the speciﬁc phosphorylation sites identi-
ﬁed in Cx43, as well as the speciﬁc kinases that facilitate their
phosphorylation. In addition to the sites and kinases shown in
Figure 2, bioinformatics has identiﬁed additional phosphoryla-
tion consensus sites in Cx43 and heat map analysis reveal that
the majority of the phosphorylation sites may be recognized by
multiple kinases (reviewed by Chen et al., 2013). In the following,
we will focus on the speciﬁc phospho-sites and kinases shown in
Figure 2, since they are all veriﬁed by biological experiments.
Ser244 AND Ser314
Ser244 and Ser314 were recently identiﬁed as potential phospho-
rylation sites in Cx43. Using high-resolution mass spectrometry
and a peptide containing the full length of the C-terminal tail of
Cx43, Huang et al. (2010) showed that Ser244 and Ser314, along
with 13 other serine sites (see Table 2), are targets for in vitro phos-
phorylation byCa2+/calmoduline-dependent kinase II (CaMKII).
CaMKII is involved in a variety of cellular processes, such as Ca2+
homeostasis, transcription and apoptosis (reviewed by Braun and
Schulman, 1995), however, the speciﬁc role of CaMKII in the regu-
lation of Cx43, andwhether phosphorylation of Ser244 and Ser314
plays a role in vivo remains to be investigated.
Tyr247 AND Tyr265
Tyr247 and Tyr265 are the only 2 out of the 21 described phos-
phorylation sites in Cx43, which are tyrosine sites, and both sites
are targets of the oncoprotein and tyrosine Src kinase. Activation
of c-Src causes direct phosphorylation of Tyr265, which leads to
reduced electrical conductance in the absence of changes in the
amount of Cx43 gap junction channels (Postma et al., 1998; Giep-
mans et al., 2001). In addition, v-Src (the constitutively active Src
kinase isoform) is reported to co-localize with Cx43 present in
the plasma membrane (Loo et al., 1999), an interaction, which
depends on the Src-homology-2 (SH2) and SH3 domains in v-
Src, as well as the Pro274-Pro284 region and phosphorylation of
Tyr265 in the cytoplasmic tail of Cx43 (Kanemitsu et al., 1997).
A study on Cx43 mutants has implied that phosphorylation of
Tyr265 alone is not sufﬁcient for complete gap junction closure.
Instead, phosphorylation of both Tyr265 and Tyr247 are required
to disruptmetabolic coupling throughCx43 gap junction channels
(Lin et al., 2001). Together, these results support a model for v-Src
induced Cx43 tyrosine phosphorylation, where interaction is ini-
tiated by binding of the v-Src SH3 domain to the Pro274-Pro284
region of Cx43. This interaction facilitates the phosphorylation
of Tyr265, which then acts as a binding site for the SH2 domain.
Binding of the v-Src SH2 domain to P-Tyr265 then strengthen the
interaction between Cx43 and v-Src and facilitates the subsequent
phosphorylation of Tyr247 and closure of the Cx43 gap junction
channel (Lin et al., 2001). This mechanism for direct Src induced
gap junction closure seems reasonable and experimentally sup-
ported. Nevertheless, a study by Zhou et al. (1999) showed that
substitution of Tyr265 and/or Tyr247 with phenylalanine (which
mimics a constitutive dephosphorylated tyrosine) did not inter-
fere with the ability of v-Src to cause electrical uncoupling of gap
junction channels. Instead, their study implied that phospho-
rylation of the mitogen-activated protein kinase (MAP kinase)
sites Ser255, Ser279, and Ser282 (which are further described
below) is essential for v-Src induced regulation of electrical cou-
pling. In addition, a recent study found that Akt activation is
crucial to disrupt dye transfer in v-Src transformed cells, but
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FIGURE 2 | Phosphorylation sites in the C-terminal tail of Cx43. This
ﬁgure represents the C-terminal tail of Connexin43 (Cx43; amino acid, aa
227–382) including its phosphorylation sites and its respective kinases.
Serine (S) phosphorylation sites are presented in red and tyrosine (Y)
phosphorylation sites are presented in purple. CaMKII, Ca2+/calmodulin-
dependent kinase II; PKG, protein kinase G; PKC, protein kinase C, MAPK,
mitogen-activated protein kinase; CK1, casein kinase 1; PKA, protein kinase
A. For references see text and Table 2.
inhibition of Akt only recovered the metabolic coupling to 60%
(Ito et al., 2010). Since Akt may cause phosphorylation of Ser369
and Ser373 in Cx43 (Park et al., 2007; for details see section on
Ser364, Ser365, Ser368, Ser369, Ser372, and Ser373), this indicates
that Src kinases controls several intracellular signaling pathways,
and thereby affects the phosphorylation of both serine and tyro-
sine residues in the C-terminal tail of Cx43 with different effects
on electrical and metabolic coupling. Together, these studies out-
lines that the control of gap junction coupling by Src kinases is
extremely complex; It depends of a combination of direct phos-
phorylation of both Tyr247 and Tyr265, as well as interplay with
several intracellular signaling pathways controlling Cx43 serine
phosphorylation.
In addition to the control of gap junction channels, Src may
also regulate gap junction localization. Binding of Src to Cx43 and
phosphorylation of Tyr265 inhibits the endogenous interaction
between Cx43 and the cytoskeleton protein zonula occludens 1
(ZO-1) in cardiomyocytes (Toyofuku et al., 2001). ZO-1 is impor-
tant for the localization of Cx43 channels at the intercalated discs
of the heart, and therefore, an interruption of the Cx43-ZO-1
interaction may reduce the amount of Cx43 present at the cell sur-
face. This is further supported by Duffy et al. (2004) who found
that intracellular acidiﬁcation in astrocytes causes Cx43 internal-
ization accompanied by decreased binding of ZO-1 and increased
binding of Src to Cx43.
Based on the complex nature of Src kinase regulation of Cx43
gap junction channels, it is not surprising that Src induced alter-
ations in gap junction coupling is found in several pathological
conditions. Since gap junction communication is essential for
controlled cell growth and cell differentiation, Src kinase induced
Cx43 phopshorylation seems to play an essential role in tumori-
genesis (reviewed by Pahujaa et al., 2007). Furthermore, tyrosine
phosphorylation of Cx43 is suggested to play a role in cardiac
arrhythmias caused by either increased activation of the renin-
angiotensin-aldosterone system or metabolic inhibition. More
speciﬁcally, it was shown that treatment with a c-Src inhibitor
interruptsAngiotensin IImediated loss of Cx43 gap junction chan-
nels and reduces the risk of ventricular tachycardia in mice with
over expression of angiotensin-converting-enzyme (ACE; Sovari
et al., 2011). Furthermore,metabolic inhibitionof culturedneona-
tal cardiomyocytes also induces tyrosine phosphorylation of Cx43
and increased association between c-Src and Cx43 (Chung et al.,
2007, 2009), which indicates a role for tyrosine phosphorylation
in gap junction uncoupling and/or remodeling during myocardial
ischemia.
Ser255, Ser279, AND Ser282
As indicated above, Ser255, Ser279, and Ser282 are all tar-
gets for MAP kinase phosphorylation (Warn-Cramer et al., 1996;
Cameron et al., 2003). In HeLa cells, Cx43 phosphorylated at
Ser255, Ser279, and Ser282 is transported correctly to gap junc-
tional plaques, but phosphorylation of Ser279 and/or Ser282
impairs channel function and decreases both electrical and
metabolic coupling (Warn-Cramer et al., 1998). In addition, a
recent study demonstrates that Ser279 and Ser282 are involved
in the regulation of gap junction plaque size in human pancre-
atic cancer cells; Johnson et al. (2013) found that phosphorylation
of Ser279 and Ser282 disrupts gap junction plaque growth by
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Table 2 | Connexin 43 post translational modification (PTM) sites including kinases responsible for phosphorylation (P).
Residue PTM (Kinase(s)) Reference
K114 SUMOylation Kjenseth et al. (2012)
K234 SUMOylation Kjenseth et al. (2012)
S244 P (CaMKII) Huang et al. (2010)
Y247 P (Src) Lin et al. (2001), Solan and Lampe (2007)
S255 P (MAPK/CaMKII) Warn-Cramer et al. (1996), Cameron et al. (2003), Huang et al. (2010)
S257* P (PKG/CaMKII) Kwak et al. (1995a), Kwak and Jongsma (1996), Huang et al. (2010)
S262 P (PKCε) Doble et al. (2004), Axelsen et al. (2006), Srisakuldee et al. (2009)
Y265 P (Src) Giepmans et al. (2001), Lin et al. (2001), Toyofuku et al. (2001), Solan and Lampe (2007)
C271 Nitrosylation Straub et al. (2011)
S279 P (MAPK) Warn-Cramer et al. (1996)
S282 P (MAPK) Warn-Cramer et al. (1996)
S296 P (CaMKII) Axelsen et al. (2006), Huang et al. (2010)
S297 P (CaMKII) Axelsen et al. (2006), Huang et al. (2010)
S306 P (CaMKII) Axelsen et al. (2006), Huang et al. (2010)
S314 P (CaMKII) Huang et al. (2010)
S325 P (CK1/CaMKII) Cooper and Lampe (2002), Huang et al. (2010)
S328 P (CK1/CaMKII) Cooper and Lampe (2002), Huang et al. (2010)
S330 P (CK1/CaMKII) Cooper and Lampe (2002), Huang et al. (2010)
S364 P (PKA/CaMKII) TenBroek et al. (2001), Shah et al. (2002), Huang et al. (2010)
S365 P (PKC/PKA/CaMKII) Shah et al. (2002), Huang et al. (2010)
S368 P (PKC) Saez et al. (1997), Lampe et al. (2000), Shah et al. (2002), Bao et al. (2004), Axelsen
et al. (2006), Ek-Vitorin et al. (2006)
S369 P (PKC/Akt/CaMKII) Shah et al. (2002), Park et al. (2007), Huang et al. (2010)
S372 P (PKC/CaMKII) Saez et al. (1997), Shah et al. (2002), Huang et al. (2010)
S372 P (PKC/Akt/CaMKII) Shah et al. (2002), Park et al. (2007), Huang et al. (2010)
*Amino acid residue 257 of rat Cx43 is a serine. In human Cx43, residue 257 is an alanine.
CaMKII, Ca2+/calmodulin-dependent kinase II; MAPK, mitogen-activated protein kinase; PKG, protein kinase G; PKC, protein kinase C; CK1, casein kinase 1; PKA,
protein kinase A. Akt is also known as protein kinase B.
triggering calthrin-mediated endocytosis of Cx43. Based upon
these results, is seems thatMAPkinase controlled phosphorylation
of Ser255 and especially Ser279 and Ser282 regulate both electric
and metabolic coupling of gap junction channels, as well as gap
junction plaque size by controlling the rate of Cx43 endocytosis.
However, the effects of MAP kinase induced Cx43 phosphoryla-
tion maybe cell type speciﬁc and further studies are needed to
determine the speciﬁc effects in vivo.
Ser257
Amino acid residue 257 of Cx43 is a serine in rats, whereas it is an
alanine in the human genome. Since alanine mimics a constitutive
dephosphorylated formof a serine, it couldbe assumed that Ser257
is not a target for phosphorylation in the rat. Nevertheless, Kwak
et al. (1995a) found that activation of PKG by 8-bromoguanosine
3′:5′-cyclicmonophosphate (8Br-cGMP) increase the incorpora-
tion of P32 into rat Cx43 but not human Cx43 expressed in
SKHep1 cells. Furthermore, phosphorylation of Cx43 by protein
kinase G (PKG) was associated with a decreased macroscopic
and single channel conductance in SKHep1 cells (Kwak et al.,
1995a). Kwak and Jongsma (1996) also showed that PKG causes
decreased macroscopic – and single channel conductance in car-
diomyocytes from rats. These data shows that electrical coupling
is regulated by PKG induced phosphorylation of Ser257 in the
rat, whereas PKG is not involved in the regulation of Cx43 in
humans.
Ser262
Fibroblast growth factor 2 (FGF2) induced stimulation of protein
kinase C (PKC; subtype ε) in cultured cardiomyocytes induces
Ser262 phosphorylation along with increased cardiomyocyte pro-
liferation (Doble et al., 2004). The same study also found that
Cx43 overexpression is associated with decreased DNA synthesis
and thereby decreased cell proliferation. In addition, the effect of
Cx43 overexpression was inhibited when Ser262 was exchanged
with aspartate that mimics a constitutive phosphorylation. These
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ﬁndings support a central role for Ser262 phosphorylation inCx43
mediated control of cell proliferation.
Ser262 phosphorylation may also play a role in cardio pro-
tection against ischemic injuries and arrhythmias. Both FGF2
and ischemic preconditioning causes increased phosphorylation
of Ser262, as well as protection against ischemic injury in iso-
lated rat hearts (Srisakuldee et al., 2009). Furthermore, expression
of a Cx43 mutant, where Ser262 is exchanged with alanine,
exacerbate injury and death of cardiomyocytes following sim-
ulated ischemia in vitro (Srisakuldee et al., 2009). In addition,
it was recently shown that Ser262 phosphorylation is essen-
tial for Cx43 interaction with the ATP sensitive K+ channel
Kir6.1 in NIH3T3 cells (Waza et al., 2012). Together these data
supports a role for Ser262 phosphorylation in ischemic cardio
protection, potentially mediated through the interaction with
Kir6.1. Nevertheless, further studies are needed to determine
exactly what the physiological consequences of the Cx43-Kir6.1
interaction are.
Ser296, Ser297, AND Ser306
That Ser296, Ser297 and Ser306 of Cx43 are subjects for phos-
phorylation was ﬁrst identiﬁed by a mass spectrometry analysis
of Cx43 puriﬁed from rat hearts (Axelsen et al., 2006). This study
further showed that Ser306 is dephosphorylated within 7 min of
cardiac ischemia, while Ser297 (together with Ser368, which will
be discussed later in this chapter) is dephosphorylated between
15 and 30 min of ischemia, where gap junction electrical uncou-
pling is also known to occur (Smith et al., 1995; Beardslee et al.,
2000). Furthermore, the study showed that the anti-arrhythmic
peptide analog rotigaptide (which is known to prevent and con-
vert conduction slowing during metabolic stress, Haugan et al.,
2005a,b) preserves Ser297 and Ser368 phosphorylation during
ischemia. The preserved phosphorylation of Ser297 and Ser368
was further correlated to a delayed onset of ischemia induced
arrhythmias (Axelsen et al., 2006). In other words, these ﬁnd-
ings indicate that dephosphorylation of Ser297 and/or Ser368 is
responsible for gap junction uncoupling during cardiac ischemia.
Another study evaluated the effect of serine to alanine substitu-
tions of Ser306, Ser296, and Ser297 in Cx43 transfected into HeLa
cells (Procida et al., 2009). Here it was found that an alanine sub-
stitution of Ser296 and Ser297 has no signiﬁcant effects on either
macroscopic electrical coupling or single channel conductance.
In contrast, substitution of Ser306 to alanine resulted in a 57%
reduction in electrical coupling, possibly mediated by a reduc-
tion of single channel conductance. Based on these ﬁndings, it
seems reasonable to conclude that several phospho-sites, includ-
ing Ser297 are Ser306 are involved in the regulation of electrical
coupling through Cx43 channels during ischemia or metabolic
stress.
The kinase(s) responsible for phosphorylation of Ser296,
Ser297, and Ser306 is still a matter of debate; While Axelsen et al.
(2006) were not able to detect CaMKII induced P32 incorporation
into a synthetic peptide containing Ser296, Ser297, and Ser306,
the previously discussed mass spectrometry based study by Huang
et al. (2010) did detect CaMKII induced phosphorylation on all
of these speciﬁc sites. Further studies are needed to clarify these
contradictory ﬁndings.
Ser325, Ser328, AND Ser330
That Cx43 phosphorylation is involved in the regulation of traf-
ﬁcking, assembly and dis-assembly, as well as the localization
of Cx43 gap junction channels was ﬁrst suggested by Musil and
Goodenough (Musil et al., 1990; Musil and Goodenough, 1991).
Since then, Cooper and Lampe (2002) have shown that casein
kinase 1 (CK1) induced phsophorylation of Ser325, Ser328, and
Ser330 in Cx43 is a key regulatory mechanism for the forma-
tion of gap junctions channels. Furthermore, it is indicated that
these speciﬁc serine phosphorylation sites are only phosphorylated
when Cx43 is located in gap junction plaques (Solan and Lampe,
2007). In further support of the importance of phosphorylation
of these speciﬁc sits, substitution of Ser325, Ser328, and Ser330 to
alanine (which mimics a constitutively dephosphorylated serine
residue) causes decreased dye coupling, as well as delayed devel-
opment of electrical coupling in mouse ﬁbroblasts (Lampe et al.,
2006).
In isolated Langendorff perfused rat hearts, Ser330 becomes
phosphorylated within 7 min of global no-ﬂow ischemia, whereas
it returns to the dephosphorylated state between 30 and 45 min
of ischemia (Axelsen et al., 2006). In addition, ischemia induced
dislocation of Cx43 from the intercalated disks to the lateral edges
of cardiomyocytes (a process known as lateralization) correlates
with dephosphorylation of Ser325, Ser328, and/or Ser330 (Lampe
et al., 2006).
Chronic hemodynamic overload also causes dephosphoryla-
tion and delocalization of atrial Cx43 in both rats and humans,
which may be related to the development of atrial ﬁbrillation
(Rucker-Martin et al., 2006). Furthermore, in mice, such hemo-
dynamic overload induced by aortic constriction causes a time-
dependent reduction in Ser325, Ser328, Ser330 phosphorylation
along with progressive loss of junctional Cx43, conduction veloc-
ity slowing and increased arrhythmogenicity (Qu et al., 2009). To
further explore the physiological signiﬁcance of Ser325, Ser328,
and Ser330 phosphorylation, Remo et al. (2011) conducted an
elegant study in mutant knock-in mice where Ser325, Ser328,
and Ser330 were replaced by either phosphomimetic glutamic
acids or non-phosphomimetic alanines. The introduction of
glutamic acid as a pseudophosphorylation resulted in gap junc-
tions that were resistant to gap junction remodeling associated
with both acute ischemia and chronic hemodynamic overload.
In contrast, the phosphorylation deﬁcient mice where Ser325,
Ser328, and Ser330 were replaced by alanines, displayed aber-
rant gap junction expression even at baseline and increased
arrhythmic susceptibility (Remo et al., 2011). Collectively, these
studies verify that the phosphorylation state of Ser325, Ser328,
and/or Ser330 plays an important role in both physiological and
pathological regulation of Cx43 gap junction localization and
function.
Ser364, Ser365, Ser368, Ser369, Ser372, AND Ser373
Ser364 is phosphorylated by protein kinase A (PKA; TenBroek
et al., 2001; Shah et al., 2002), while Ser365 may be phosphory-
lated by both PKA and PKC (Shah et al., 2002). PKC is also known
to phosphorylate Ser368, Ser369, Ser372, and Ser373 (Saez et al.,
1997; Lampe and Lau, 2000; Shah et al., 2002; Bao et al., 2004).
Even though Cx43 is a relatively poor substrate for PKA compared
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to PKC, it was shown that initial PKA activation accelerates subse-
quent PKC phosphorylation (Shah et al., 2002). The link between
PKA and PKC phosphorylation is further supported by the ﬁnd-
ing that FSH-induced Cx43 phosphorylation, which is mediated
by PKC, is depressed by the use of the selective PKA inhibitor H89
(Yogo et al., 2006).
Besides being a potential target for both PKA and PKC, Ser365
is proposed to be a“gatekeeper,”which controls the ability of other
serine residues in Cx43 to become phosphorylated. More specif-
ically, it was reported that phosphorylation of Ser365 causes a
conformational change in the c-terminal region of Cx43, which
prevents PKC induced phosphorylation of Ser368 (Solan et al.,
2007). These data underline the complexity of Cx43 phosphory-
lation and demonstrate that the phosphorylation state of one site
may inﬂuence the ability of other sites to become phosphorylated.
Along with the ability of PKC to phosphorylate Cx43 at
several serine residues, activation of PKC by 12-O-tetradecanoyl-
phorbol 13-acetate (TPA), is also known to increase cardiac
macroscopic conductance along with reduced single-channel con-
ductance (Kwak et al., 1995b; Lampe et al., 2000). This PKC effect
on gap junction conductance is, however, prevented when Ser368
is exchanged with an alanine (Lampe et al., 2000). These ﬁndings
suggest that PKC induced Cx43 phosphorylation, and especially
phosphorylation of Ser368, affects electrical coupling and the open
probability of gap junction channels.
The role of Ser368 phosphorylation during myocardial
ischemia and its connection to electrical conductance is, however,
subject of contradicting ﬁndings. As earlier mentioned, Axelsen
et al. (2006) found that Ser368 becomes dephosphorylated during
no-ﬂow ischemia in isolated rat hearts, at a time course similar
to that of electric uncoupling (Smith et al., 1995; Beardslee et al.,
2000). In addition, rotigaptide, which prevents and reverse con-
duction slowing during metabolic stress (Haugan et al., 2005a,b)
and suppresses the development of cardiac arrhythmias (Xing
et al., 2005; Axelsen et al., 2006), preserved phosphorylation of
Ser368 during ischemia (Axelsen et al., 2006). Based on this study,
it is tempting to conclude that preservationof Ser368phosphoryla-
tion contributes to an improved electrical coupling during cardiac
ischemia. The ﬁndings by Axelsen et al. (2006) are, however, in
contrast to ﬁndings by Ek-Vitorin et al. (2006). They reported
that phosphorylation of Ser368 causes a reduction in gap junc-
tion conductance and that 30 min of no-ﬂow ischemia in excised
mice hearts results in increased levels of Ser368 phosphoryla-
tion, despite an overall Cx43 dephosphorylation when examined
by western blotting. Currently, there are no clear explanations
for these contradicting ﬁndings and further research is needed
to clarify to role of Ser368 phosphorylation during pathological
conditions.
In addition to the regulatory role of Ser368 with respect to
electrical coupling, the Cx43 PKC phosphorylation sites are also
involved in the regulation of metabolic coupling. In HeLa cells, it
was found that alanine substitutions of Ser365, Ser368, Ser369,
and Ser373 all at once, cause a marked drop in gap junction
dye transfer (Yogo et al., 2002). This effect on metabolic coupling
was, however, blunted if the alanine substitution was restricted to
Ser368. These ﬁndings suggest that while dephosphorylation of
Ser368 alone seems sufﬁcient to alter the electrical coupling, the
metabolic coupling appears to depend on several of the speciﬁc
PKC sites. In contrast to the ﬁndings in HeLa cells, where reduced
metabolic coupling is related to Cx43 dephosphorylation, PKC
mediated increases in Cx43 phosphorylation reduces metabolic
coupling in both ﬁbroblasts (Lampe et al., 2000) and neonatal
cardiomyocytes (Kwak et al., 1995b). The reason for these contra-
dicting ﬁndings on the connection between metabolic coupling
and the phosphorylation state of Cx43 is currently unknown. It
could, however, simply be a matter of the different cell-systems
used and further studies are needed in order to determine the
effect in vivo.
As described above, phosphorylation of Ser369 and Ser373 can
be mediated by PKC. Both these sits are, however, also subject
to phosphorylation by Akt kinase (also known as protein kinase
B) (Park et al., 2007). Akt induced phosphorylation of Ser369
and Ser373 facilitates an interaction between Cx43 and 14-3-3,
which plays a role in trafﬁcking of Cx43 multimers and/or their
incorporation into gap junction plaques (Park et al., 2007).
Finally, the previously discussed mass spectrometry study by
Huang et al. (2010) also identiﬁed Ser364, Ser365, Ser369, Ser372,
and Ser373 as CaMKII targets in vitro. However, it is still unknown
whether CaMKII phosphorylates Cx43 in vivo and the poten-
tial physiological role of CaMKII induced Cx43 phosphorylation
remains to be established.
THE ROLE OF PROTEIN PHOSPHATASES
Most experimental studies have focused on the protein kinases,
which are responsible for Cx43 phosphorylation. Nevertheless,
regulation of Cx43 phosphorylation is not only dependent on
the kinases, but also on the equilibrium between protein phos-
phatase and kinase activity. Even so, experimental data regarding
the phosphatases that dephosphorylate Cx43 remain limited.
Under normal physiological conditions, both protein phos-
phatase 1 (PP1) and protein phosphatase 2A (PP2A) co-localize
with Cx43 in rabbit hearts (Ai and Pogwizd, 2005), indicating a
physiological role for these enzymes in the regulation of Cx43. The
role of these endogenous protein phosphatases on Cx43 gap junc-
tion uncoupling during ischemia or ATP-depletion have further
been evaluated inneonatal rat cardiomyocytes, adult rat cardiomy-
ocytes, as well as isolated rat hearts; in neonatal cardiomyocytes,
selective PP1 inhibitors postpone electrical uncoupling of gap
junctions during ATP-depletion (Duthe et al., 2001). At the same
time, addition of a speciﬁc PP1 stimulator facilitated a gradual
decrease in electrical coupling, even in the presence of ATP (Duthe
et al., 2001). Likewise, PP1 inhibitors decreased Cx43 dephos-
phorylation during ischemia in both isolated perfused rat hearts
and adult cardiomyocytes (Jeyaraman et al., 2003). This study
also found that treatment with the selective PP2A inhibitor fos-
triecin did not prevent Cx43 dephosphorylation during ischemic
conditions. This indicates that PP1 is the key player in Cx43
dephosphorylation during ischemia in the rat.
Both PP1 and PP2A are also expressed in mini pig hearts,
but in contrast to what was found in rabbit hearts, only PP2A
co-localizes with Cx43 in the mini pig (Totzeck et al., 2008). Fur-
thermore, when isolated mini pig hearts were exposed to 90 min
of low ﬂow ischemia, it resulted in Cx43 dephosphorylation along
with an increase in total PP2A levels. The amount of Cx43-PP2A
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co-precipitation was, however, not affected during ischemia and
ischemic pre-conditioningpreservedCx43phosphorylation,with-
out any effect on either PP2A levels or activity (Totzeck et al.,
2008). In contrast to the ﬁndings during cardiac ischemia, another
study have reported a >2.5-fold increase in the amount of PP2A,
which co-localizes with Cx43 in a rabbit model of non-ischemic
heart failure (Ai and Pogwizd, 2005). The increase in PP2A-Cx43
co-localization was further associated with increased levels of
dephosphorylated Cx43 and decreased metabolic coupling, which
was prevented in the presence of okadaic acid in a concentration,
which should only inhibit PP2A.The same study also examined the
amount of co-localized Cx43 and PP1, before and after long-term
aortic constriction, but here they found no changes (Ai and Pog-
wizd, 2005). Together, these studies show that both PP1 and PP2A
may affect Cx43 phosphorylation in vivo. Based on the available
data, it seems that PP1 is the main player during acute dephospho-
rylation of Cx43, as seen during cardiac ischemia, whereas PP2A
may become the dominant player during long-term pathological
alterations such as non-ischemic heart failure. The different results
may, however, also be species dependent and further studies are
needed before the ﬁnal conclusion can be drawn.
A PERSPECTIVE ON CONNEXIN43 PHOSPHORYLATION
As outlined above, phosphorylation of Cx43 has been a sub-
ject for intense investigation for more than three decades. These
investigations have clariﬁed that the regulation of Cx43 gap junc-
tion channels by phosphorylation is an extremely complex matter,
which includes at least 21 different phosphorylation sites and a
growing list of more than 10 different kinases and phosphatases.
In addition, it is now clear that the different phosphorylation
sites may interact and depend upon each other and site speciﬁc
changes in phosphorylation may exert different effects on electric
and metabolic coupling. Furthermore, it seems that the effects
of altered Cx43 phosphorylation may be both species and cell
type dependent. All of these considerations should be taken into
account when planning future studies on Cx43 phosphorylation,
as well as during the interpretation of such studies.
PHOSPHORYLATION OF CONNEXIN26
For many years, it was generally thought that Cx26 was not
a phospho-protein, because of its fairly short C-terminal tail,
consisting of only 11 amino acids. A mass spectrometry study,
however, showed that Cx26 is phosphorylated in the intracellu-
lar N-terminal tail at either position Asp2, Thr5, or Ser8 when
expressed in HeLa cells (Locke et al., 2006). Importantly, the same
phosphorylation was not detected in Cx26 from liver tissue, where
the same amino residues were found to be hydroxylated instead
(Locke et al., 2006). In a later study, Harris and Locke (2009) also
found indications for potential phosphorylation sites in the cyto-
plasmic loop (Thr123) and the extracellular loop (E2; Thr177,
Ser183 and Thr186) of Cx26 (Locke et al., 2009). Nevertheless, the
physiological role of Cx26 phosphorylation remains unknown.
PHOSPHORYLATION OF CONNEXIN32
As for Cx26, Cx32 also contains phosphorylation sites in the N-
terminal domain, more speciﬁcally Thr4, Tyr7, Thr8, or Ser11,
which was identiﬁed as phosphorylated in Cx32 from both HeLa
cells and mouse liver (Locke et al., 2006). In addition, Cx32 from
HeLa cells was phosphorylated in the C-terminal tail at position
His237, Ser233, and/or Ser240 (Locke et al., 2006). In support
of the ﬁndings by mass spectrometry, work on isolated hepato-
cytes have shown that both PKA and PKC may phosphorylate
Ser233, whereas CaMKII may phosphorylate other serine and
threonine sites in Cx32, but not Ser233 (Saez et al., 1990). Cx32
is also identiﬁed as a target for epidermal growth factor (EGF)-
receptor tyrosine kinase (Díez et al., 1998). The speciﬁc tyrosine
residue(s), which is/are targeted by EGF-receptor tyrosine kinase,
was not revealed, but the study showed that binding of calmodulin
to Cx32 prevented EGF-receptor tyrosine kinase induced phos-
phorylation. Based on this ﬁnding, it is likely that the target for
EGF-receptor tyrosine kinase phosphorylation is located in one
of the calmodulin binding sties in Cx32, which is amino acid no.
1–27 in the N-terminal tail and amino acid no. 216–230 located in
the C-terminal tail (Török et al., 1997).
Further experimental studies are needed in order to reveal to
physiological role of Cx32 phosphorylation in biological systems.
PHOSPHORYLATION OF CONNEXIN40
Cx40 is also regulated by post-translational phosphorylation
(Traub et al., 1994; van Rijen et al., 2000), but the speciﬁc sites
are yet to be studied in detail. So far, it is known that both PKA
and PKC are able to incorporate P32 into Cx40 in transfected
human cells and that 8-Br-cAMP induced PKA activation causes
an electrophoretic mobility shift of Cx40. Furthermore, van Rijen
et al. (2000) showed that Cx40 gap junction channels increase
both macroscopic conductance and metabolic coupling, when
subjected to PKA-induced phosphorylation in SKHep1 cells.
Recently, it was also shown that reduced serine phosphoryla-
tion of Cx40 correlates with reduced electrical coupling between
microvascular endothelial cells (EC) during sepsis (Bolon et al.,
2008). This process was prevented by PKA activation and mim-
icked in control cells by PKA inhibition, which indicates that the
involved phosphorylation site(s) is/are a target for PKA.
Since Cx40 is the predominant connexin found in the atria,
it can be hypothesized that dephosphorylation of Cx40 and
decreased electrical coupling in the atria may play a role in
the patogenisis of atrial ﬁbrillation. This, however, remains an
interesting question for future research.
PHOSPHORYLATION OF CONNEXIN45
Cx45 is expressed in many different tissues and the only member
of the connexin family, whose absence is lethal in the embryonic
state (Kruger et al., 2000; Kumai et al., 2000). Even so, the post-
translational regulation of Cx45 has been less extensively studied
compared to other connexins. Serine phsophorylation of Cx45 is
found in both mouse kidney (Butterweck et al., 1994), cultured
neonatal rat ventricular myocytes (Darrow et al., 1995), as well as
inHeLa transfectants (Hertlein et al., 1998). The latter study found
that exchange of the serine residues at position 374, 376, 378, 381,
382, 384, 385, 387, and 393 for other amino acids or deletion of this
part of the carboxy-terminal led to an 89% decrease in the phos-
phorylation signal. This indicates that these nine serine residues
are the main sites for Cx45 phopshorylation. They did, however,
also ﬁnd signals for phosphothreonine and phosphotyrosine after
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metabolically labeling with 32P-orthophosphate. Even when all
the above mentioned carboxy-terminal serine residues of Cx45
were replaced, it did not interfere with intracellular trafﬁcking or
assembly of gap junction channels at the plasma membrane. Fur-
thermore, HeLa cells transfected with the Cx45 mutant showed
the same extend of dye transfer as cells transfected with wild type
Cx45 (Hertlein et al., 1998). Instead, they found that mutation of
the nine serine residues in the cytoplasmic tail caused an increased
Cx45 degradation. When all nine serine residues or the double ser-
ine residues Ser381 – Ser382 or Ser384 – Ser385 were exchanged,
the Cx45 half-life time was reduced with up to 50%.
A recent study based on tandemmass spectrometry showed that
CaMKII and CK1 phosphorylates Cx45 in vitro (Bao et al., 2011).
Speciﬁcally, CaMKII was found to phosphorylate serine 326, 381,
382, 384, 385, 387, and 393 alongwith threonine 337, whereas CK1
phosphorylate serine 326, 382, 384, 387, and 393. Another study,
also based on HeLa cells transfected with Cx45, reported that acti-
vation of PKA and MAP kinase increases Cx45 phosphorylation
when analyzed bywestern blotting (vanVeen et al., 2000). PKAand
MAP kinase induced Cx45 phosphorylation was associated with
a decreased macroscopic junctional conductance, whereas acti-
vation of PKC was found to increase macroscopic conductance of
Cx45 channels. However, the effect of PKCoccurred in the absence
in any apparent changes in Cx45 phosphorylation. Together, all of
these studies show that Cx45 contains several phosphorylation
sites, which are involved in the regulation of Cx45 degradation
and macroscopic conductance, at least in HeLa cells. However, the
role of Cx45 phosphorylation in vivo during both physiological
and pathophysiological conditions remains an open question for
future research.
PHOSPHORYLATION OF Cx46 AND Cx50
Cx46 and Cx50 are known to combine and form heteromeric gap
junction channels in ocular lens ﬁbers and both connexins play
an important role in lens growth and maintenance of lens trans-
parency. Mass spectrometry analysis of Cx46 and Cx50 isolated
from bovine lenses identiﬁed a total of 11 and 18 phosphorylation
sites, respectively (Wang and Schey, 2009). All of the identiﬁed
phosphorylation sites in Cx46 are located in the C-terminal tail,
whereas three of the identiﬁed sites in Cx50 are located in the cyto-
plasmic loop. The physiological response to alteredCx46 andCx50
phosphorylation is not yet fully understood. In chicken, how-
ever, caspase-3-like protease induced truncation of lens Cx45.6
(the chicken homolog of Cx50) is inhibited by casein kinase II
(CKII) induced phosphorylation of Ser363 (Yin et al., 2001). Cal-
pain mediated cleavage of lens Cx46 and Cx50 is proposed to
occur naturally during the maturation of lens ﬁbers (Lin et al.,
1997; Yin et al., 2001), and the data by Yin et al. (2001) implies
that Cx46 and Cx50 cleavage may be regulated by Cx46 and Cx50
phosphorylation.
UBIQUITINATION
Ubiquitin is a 76 amino acid polypeptide that is found in
almost all eukaryotic cells. Structurally, it consists of a glob-
ular domain, formed by a β-sheet and an α-helix, with the
N- and C-termini protruding out. It is important for protein
trafﬁcking, in particular for labeling proteins for proteosomal
destruction and recycling. Aaron Ciechanover, Avram Her-
shko, and Irwin Rose were awarded the Nobel Prize in Chem-
istry in 2004 for the discovery of ubiquitin-mediated protein
degradation.
The enzymatic process of ubiquitin binding (ubiquitination
or ubiquitinylation) to a target protein begins with activation
of ubiquitin by an E1 ubiquitin activating enzyme that forms
a bond between the carboxyl group of the C-terminal glycine
residue (Gly 76) of ubiquitin and an E1 cysteine. This step is fol-
lowed by transfer of ubiquitin from E1 to a cysteine residue of the
ubiquitin-conjugating enzyme E2. Finally, the E2-ubiquitin con-
jugated enzyme associates with an E3 ubiquitin-protein ligase (as
reviewed by Schulman and Harper, 2009; Weissman et al., 2011).
The E3 enzymes function as substrate recognition module and
facilitates the formation of a bond between a lysine of the target
protein and the C-terminal glycine of ubiquitin. In most organ-
isms, there is only one E1, several different E2 and hundreds of E3s.
By determining the timing and the substrate of the ubiquitination
process, the E3 ubiquitin-protein ligases are the central regulatory
determinants of the ubiquitination process. The E3 ubiquitin-
protein ligases can be classiﬁed into (1) The HECT (homologous
to E6-AP carboxy terminal) E3s (Huibregtse et al., 1995), (2) The
RING (really interesting new gene) E3s (Lorick et al., 1999) or the
closely related U-box E3s.
Homologous to E6-AP carboxy terminal E3 participates
directly in ubiquitination by forming a bond with ubiquitin prior
to the transfer of ubiquitin to the target protein. HECT E3s con-
tains 3 WW domains, WW1–3. WW domains are short domains
contain 38 to 40 amino acid residues, including two conserved
tryptophan residues, hence the name WW domain. The domain
form a triple-stranded β sheet that binds proteins with particu-
lar proline-motifs (PY motifs, XXPPXY, where P is a proline, X
is any amino acid and Y is tyrosine) and/or phosphoserine and
phosphothreonin containing motifs and thereby mediate target
recognition (Nguyen et al., 1998).
An ubiquitin molecule contains a total of seven lysine residues.
Following addition of a single ubiquitin to a protein (monoubiqui-
tination), further ubiquitin molecules can be conjugated to lysine
residues in the boundubiquitin, resulting in a polyubiquitin chain.
The ﬁrst identiﬁed type of polyubiquitin chains were linked via
lysine 48 (Lys48 forming an isopeptide bond to Gly76), however,
a wide variety of linkages involving all possible lysine residues
(Lys6, 11, 27, 29, 33 and 63) have been demonstrated, reviewed
by (Ikeda and Dikic, 2008; Kulathu and Komander, 2012). Fur-
ther, some substrates contain multiple lysine residues that can be
modiﬁed by addition of ubiquitin molecules or ubiquitin chains
(multiubiquitination).
The various types of ubiquitin modiﬁcations have been
linked to distinct physiological functions in cells. Multi-
monoubiquitination is associated with DNA repair and receptor
endocytosis, and lysosomal degradation or recycling to the sur-
face (Dikic et al., 2009) whereas lysine 48-linked polyubiquitin
chains label proteins for proteasomal degradation (Hershko and
Ciechanover, 1998). Homotypic ubiquitin chains (e.g., chains
consisting of only Lys6, 11, 27, or 29 linkages) are also found,
and may be involved in different cellular processes such as sig-
naling, trafﬁcking, DNA damage response, cell cycle regulation
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or endoplasmic reticulum associated degradation (ERAD) as
reviewed by (Komander, 2009).
UBIQUITINATION OF CONNEXINS
Ubiquitination may be involved in several important steps in the
life cycle of connexins (reviewed by Kjenseth et al., 2010 and Su
and Lau, 2012). The newly synthesized connexins undergo qual-
ity control in the endoplasmic reticulum and polyubiquitination
targets misfolded connexin proteins to ERAD and proteasomal
degradation (VanSlyke and Musil, 2002). CIP75 (connexin inter-
acting protein 75) facilitates this process (Li et al., 2008). After
insertion into gap junction plagues in the membrane, ubiqui-
tination by the E3 ubiquitin ligase Nedd4 is thought to target
connexins for endocytosis and lysosomal degradation (Leykauf
et al., 2006). The connexins remain ubiquitinated throughout the
internalization process that is assisted by EGF receptor pathway
substrate 15 (Esp15; Girao et al., 2009). In the early endo-
somes, the ubiquitin binding proteins Hrs (hepatocyte growth
factor-regulated tyrosine kinase substrate) and Tsg101 (tumor
susceptibility gene product 101) interacts with ubiquitinated con-
nexins and determines whether the connexins are targeted for
recycling or for deubiquitination followed by degradation (Leithe
et al., 2009). Connexins targeted for destruction may follow sev-
eral alternative endocytotic pathways, however, there is increasing
evidence suggesting that the ﬁnal destination is lysosomal degra-
dation (Laing et al., 1997; Musil et al., 2000; Girao and Pereira,
2003; Rivedal and Leithe, 2005; Piehl et al., 2007; Falk et al.,
2012).
ERAD AND CIP75
Approximately 40% of newly synthesized Cx43 and Cx32 may
undergo ERAD (VanSlyke and Musil, 2002). The level of ERAD
is strongly dependent on cellular stress. Oxidative and thermal
stress reduce ERAD and more connexins reach the membrane and
form functional gap junctions (VanSlyke and Musil, 2002). The
mechanism behind cellular stress-induced ERAD is not known
(VanSlyke and Musil, 2002). Interestingly, a Cx32 mutation, where
Glu 208 is replaced by a lysine from a patient withX-linked periph-
eral neuropathy Charcot-Marie-Tooth was found to cause nearly a
100% of the newly synthesized Cx32 to undergo ERAD (VanSlyke
et al., 2000; Kelly et al., 2007), however, under cellular stress, the
polyubiquitination of this Cx32 mutation is reduced. The mutated
proteins accumulate in the ER and may contribute to the disease
by co-assembling with wild type connexin (VanSlyke et al., 2000;
Kelly et al., 2007).
The CIP75 protein is involved in ERAD by translocating
the ubiquitinated connexins across the endoplasmatic reticu-
lum membrane as well as bringing the connexins targeted for
degradation to the proteasomes during the ERAD process (Li
et al., 2008). The Cx43 C-terminal harbors a proline-rich area
corresponding to the PY motif (Thomas et al., 2003a), that is
important for E3 ubiquitin-ligase target recognition (Nguyen
et al., 1998). The interaction between CIP75 and Cx43, takes place
between a C-terminal ubiquitin-associated domain of CIP75 and
this PY motif, as well as multiple phosphorylation sites located
between Lys264 and Asn302 of Cx43 (Li et al., 2008). CIP75 con-
tains domains that interact with the proteasomal complex and
overexpression experiments suggested that CIP75 stimulates pro-
teasomal degradation of Cx43 (Li et al., 2008). CIP75 can bind
free mono-ubiquitin and Lys48-linked ubiquitin chains in vitro as
well as ubiquitinated proteins in cellular lysates (Su et al., 2010).
However, it was demonstrated that Cx43 associated with CIP75
is not ubiquitinated, and a mutant form of Cx43 lacking lysine
residues and thus incapable of ubiquitination retained the capac-
ity to interact with CIP75. This suggests that although CIP75 can
interact with ubiquitinated proteins, its interaction with Cx43 and
stimulation of Cx43 proteasomal degradation does not necessarily
require ubiquitination (Su et al., 2010).
UBIQUTINATION AND INTERNALIZATION OF CONNEXINS IN GAP
JUNCTIONAL PLAQUES
Laing and Beyer (1995) were the ﬁrst to describe ubiquitination of
Cx43 and ubiquitin-mediated proteasomal degradation. Protea-
somal inhibition and inactivation of the E1 ubiquitin activating
enzyme resulted in stabilization of Cx43 at the plasma membrane.
It was later found that 50% of Cx43 plaques are ubiquitinated,
however, ubiquitination is most predominant in older plagues,
suggesting that ubiquitination may signal endocytosis of older gap
junction from the plasmamembrane to the lysosomes for degrada-
tion (Laing et al., 1997; Musil et al., 2000; Girao and Pereira, 2003;
Rivedal and Leithe, 2005). The role of the proteasomes in endo-
cytosis and degradation of connexins from gap junctional plaques
is not clear. Several studies have demonstrated that endocytosis of
Cx43 is repressed in the presence of proteasomal inhibitors, sug-
gesting that there may be an intricate interplay between lysosomes
and proteasomes as reviewed in (Kjenseth et al., 2010; Falk et al.,
2012).
The E3 ubiquitin ligase Nedd4 (neural precursor cell expressed,
developmentally downregulated 4) was the ﬁrst E3 ubiquitin lig-
ase to be shown to interact with connexin (Leykauf et al., 2006).
Nedd4 is thought to play an important role in the regulation of
connexins in gap junction plaques and ubiquitination by Nedd4
targets connexins for internalization (Leykauf et al., 2006; Girao
et al., 2009).
Nedd4 belongs to the HECT family of E3 ubiquitin ligases
(Huibregtse et al., 1995) and contains three WW domains. The
interaction between Nedd4 and Cx43 takes place between the
PY motif of the Cx43 C-terminus (Leykauf et al., 2006; Girao
et al., 2009) and the three WW domains of Nedd4 (Leykauf et al.,
2006). WW1 andWW2 domains mainly interact with the unphos-
phorylated form of Cx43, whereas WW3 binds phosphorylated
and unphosphorylated forms equally (Leykauf et al., 2006). Only
the WW2 domain binds to the PY motif (Leykauf et al., 2006).
Other groups have demonstrated interaction of Cx43 with addi-
tional E3 ligases, including the other members of the HECT
family smad ubiquitination regulatory factor-2 (Smurf2; Fykerud
et al., 2012) and WWP1 as well as the RING E3 ligase Tripartite
motif-containing protein 2 (TRIM21) as reviewed by Su and Lau
(2012).
EPIDERMAL GROWTH FACTOR MAY STIMULATE UBIQUINATION OF
CONNEXINS IN GAP JUNCTIONAL PLAQUES
Many growth factors, such as EGF and tumor promotors, includ-
ing TPA inhibits intercellular communication by inducing Cx43
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ubiquination followedby endocytosis anddegradation (Leithe and
Rivedal, 2004a; Leithe et al., 2009; Sirnes et al., 2009). In rat liver
epithelial cell lines, application of EGF activates the MAP kinase
pathway resulting in Cx43 hyperphosphorylation (Lau et al., 1992;
Kanemitsu and Lau, 1993; Leithe and Rivedal, 2004a) on Ser255,
279 and 282 in the C-terminus of Cx43 (Warn-Cramer et al., 1996,
1998). The EGFmediated hyper-phosphorylation of Cx43was fol-
lowed by ubiquitination resulting in a rapid transient decrease in
intracellular coupling (Leithe and Rivedal, 2004a). However, EGF
does not only uncouple gap junctions, they also induce disorgani-
zation, endocytosis and degradation of Cx43 plaques (Leithe and
Rivedal, 2004a).
Besides stimulating the MAP kinase pathway, EGF activates
phospholipase C, resulting in hydrolysis of phosphatidylinositol
4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3)
and diacylglycerol (DAG; van Rheenen et al., 2007). Reduced
PIP2 levels inhibit gap junctional coupling in both ﬁbrob-
lasts (van Zeijl et al., 2007) and cardiomyocytes (Hofgaard et al.,
2008). Stimulation of cultured cardiomyocytes from neonatal
rats with noradrenaline or angiotensin II decrease cell cou-
pling and action potential conduction velocity mediated via a
decrease in PIP2 levels (Hofgaard et al., 2008) and in a later
study it was demonstrated that noradrenaline induced uncou-
pling was associated with ubiquitination of Cx43, possibly via
Nedd4, and subsequent internalization of Cx43 (Mollerup et al.,
2011).
The tumor promoting phobol ester TPA activates the MAP
kinase pathway, as well as PKC (Leithe and Rivedal, 2004a; Sirnes
et al., 2009). This in turn induce hyperphosphorylation of Cx43
followed by monoubiquitination at multiple sites (Leithe and
Rivedal, 2004b; Leithe et al., 2006). Eps15 is recruited to the
membrane to facilitate endocytosis of Cx43 (Girao et al., 2009).
Ubiquitination may also be important for the transport from the
endosome to the lysosomes, a process facilitated by Hrs and tsg101
(Leithe et al., 2009).
Recently, the role of ubiquitination in regulation of Cx43 gap
junction turnover was questioned in a study by Dunn et al. (2012).
They demonstrated that a Cx43 construct, where all lysine residues
were replaced by arginine residues, behaved similarly to wild-type
(Dunn et al., 2012). This is in line with the failure to identify a
speciﬁc lysine acceptor for ubiquitination on Cx43 and may imply
that ubiquitination of Cx43 is not crucial for regulation of Cx43
gap junction turn over. As Cx43 localization is regulated by phos-
phorylation, the authors hypothesized that another ubiquitinated
protein may regulate Cx43 retention or degradation. Since phos-
phorylation is crucial for localization and activity of Cx43, the
effect of inhibitors of the various kinases know to affect Cx43 was
tested. These experiments suggests that Akt activity controls gap
junction stability through phosphorylation (Dunn et al., 2012).
When Akt is activated by phosphorylation it translocates to the
plasma membrane, where it phosphorylates membrane proteins,
inclusive Cx43 on Ser373 and Ser369 (Park et al., 2007), result-
ing in stabilization of gap junction plaques (Dunn et al., 2012).
Interestingly, Akt is a target for ubiquitination and proteasomal
degradation (Yang et al., 2009), which may potentially explain
the effect of proteasomal and lysosomal inhibitors on connexin
expression.
SUMOYLATION
Small ubiquitin-like modiﬁer (SUMO) proteins are a small family
of proteins that are structurally and functionally related to ubiq-
uitin. In humans, the SUMO protein family consists of 3 members
(SUMO1-3). SUMO 2 and 3 show a high degree of similarity
(Saitoh and Hinchey, 2000). The structural folding of SUMO pro-
teins is similar to that of ubiquitin, but there is little overlap in
the amino acid sequence. The consensus motif for SUMOyla-
tion is KXD/E where  is a large hydrophobic residue, K is the
acceptor lysine, X is any amino acid followed by an acidic residue
(Rodriguez et al., 2001)
Analog to ubiquitination, SUMOylation is controlled by an
enzymatic cascade resulting in covalently attachment of SUMO
to lysine residues in the target protein (reviewed by Hay, 2005
and Gareau and Lima, 2010). A C-terminal peptide is cleaved
from SUMO by sentrin-speciﬁc proteases (SENPs) to reveal a di-
glycine motif. SUMO then becomes bound to an E1 enzyme (or
SUMO activating enzyme, SAE). It is then passed to an E2, which
is a conjugating enzyme, Ubc9, which is able to directly recognize
substrateswith a SUMOylation consensusmotif (reviewed byHay,
2005). However, the SUMO moiety can also be transferred to one
of a small number of E3 ligating proteins that conjugates SUMO
to target proteins. While in ubiquitination an E3 ligating protein is
essential for the process, evidence suggests that the E2 is sufﬁcient
in SUMOylation, as long as the consensus sequence is present.
The SUMO moieties can be removed by SENPs that serve dual
functions in the SUMOylation circle (Gareau and Lima, 2010).
SUMO2 and SUMO3 contains the SUMOylation consensusmotif,
which can be utilized to form poly-SUMOylation chains on the
target protein (reviewed by Hay, 2005; Gareau and Lima, 2010).
In contrast to ubiquitination, SUMOylation is not used to tar-
get proteins for degradation but is rather involved in the regulation
of various cellular processes, including transcriptional regulation,
protein targeting and stability, response to stress, progression
through cell cycle and apoptosis (Geiss-Friedlander and Melchior,
2007).
CONNEXINS AND SUMOYLATION
Connexins was ﬁrst described to be regulated by SUMOylation by
Kjenseth et al. (2012). In transfected HeLa cells, all three mem-
bers of the SUMO family increased Cx43 expression and gap
junction formation. SUMO2-3 had the strongest effect, result-
ing in a doubling of Cx43 expression and for Cx43 coexpressed
with SUMO3, an increased intracellular communication was
demonstrated (Kjenseth et al., 2012).
As previously described, the Cx43 N-terminus contains 3 lysine
residues, the intracellular loop 11 and the C-terminus contains 9
residues, but none of these are found in a SUMOylation consen-
sus motif. However, mutational scanning revealed that SUMO1-3
conjugated SUMO groups to Lys144 found in the intracellular
loop and Lys237 in the proximal C-terminus of Cx43 (Kjenseth
et al., 2012). Lys144 and 237 are evolutionary conserved in Cx43,
and interestingly, Lys144 is also conserved in 8 out of 20 human
connexins isoforms, including Cx26 and Cx32 (Kjenseth et al.,
2012) suggesting that other connexins may also be regulated by
SUMOylation. Directly downstreamof Lys144 is a large hydropho-
bic residue and thus this region may function as an inverted
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SUMOylation consensus motif as described (Matic et al., 2010).
Cx43 proteins, where Lys144 or 237 were replaced by arginine
residues, had reduced Cx43 gap junction formation and reduced
protein levels (Kjenseth et al., 2012). In addition to lysine 144 and
237, other lysines may be SUMOylated.
For SUMO1 or SUMO2, Cx43 was conjugated to single
moieties, whereas for SUMO 3 multiple proteins could be con-
jugated to Cx43, either as multiple mono-SUMOylation or as
poly-SUMOylation (Kjenseth et al., 2012). The majority of the
SUMOylated Cx43 was found in the Triton X-100 soluble fraction
(Kjenseth et al., 2012), suggesting that Cx43 were not organized
in functional gap junctions as gap junction plaques are Triton
X-100 insoluble (Musil and Goodenough, 1991; VanSlyke and
Musil, 2000). However, gap junctions seem to aquire Triton sol-
ubility before internalization (Sirnes et al., 2008) and work in
cultured cardiomyocytes show that inhibition of the proteasome
and lysosome increase both Triton solubility of Cx43 and intercel-
lular coupling simultaneously, indicating that communicating gap
junctions can be part of the soluble fraction (Mollerup et al., 2011).
The molecular mechanism behind the SUMOylation medi-
ated increase in Cx43 protein level is not presently known. It is
also unknown, in which subcellular compartment SUMOylation
takes place and further studies are needed to determine whether
SUMOylation affects intracellularCx43 trafﬁcking (Kjenseth et al.,
2012).
NITROSYLATION
Recent evidence suggests that S-nitrosylation of cysteine residues
may be an important post-translationalmodiﬁcation of connexins
(Retamal et al., 2006, 2009; Straub et al., 2011). S-nitrosylation is
the reversible, covalent addition of NO to the thiol side chain
of cysteine and nitrosylation appears to be the major mecha-
nism through which NO exerts its effects on cellular function
(Hess et al., 2005; Anand and Stamler, 2012; Hess and Stamler,
2012). The degree of nitrosylation is subject to dynamic regulation
through the concerted activity of multiple nitrosylases and deni-
trosylases, i.e., enzymes that adds or removes NO groups to/from
proteins (Hess and Stamler, 2012). Although many proteins con-
tain multiple cysteins, and therefore have many potential sites for
nitrosylation, it appears as if only a few of the potential sites are
actually subject to nitrolysation, and consequently, that the effects
on protein function results from the modiﬁcation of only one or
a few –SH groups in a given protein (Hess and Stamler, 2012).
Nitrosylation may directly inﬂuence protein function, but inter-
estingly may also have an indirect effect through modiﬁcation
of other post-translational modiﬁcations, e.g., phosphorylation,
acetylation or ubiquitination (Hess and Stamler, 2012).
NITROSYLATION OF CONNEXINS
NO has been shown to affect both gap junctions and hemichan-
nels, but only a few studies provides direct evidence showing that
the effect is correlated to changes in nitrosylation of the connex-
ins. In the vascular wall themyoendothelial junctions (MEJs) plays
an important role in coordinating the activity of EC and vascu-
lar smooth muscle cells (VSMC; Sandow et al., 2012). The MEJs
form where cellular extensions from the VSMC meet the EC, and
heterotypic junctions are formed at the site of contact between
the plasma membranes from the two cell types. In the VSMC,
the major connexins present are Cx43 and Cx45, whereas Cx37
and Cx40 are found in the EC (Sandow et al., 2012). Interestingly,
the MEJ also appears to have a high content of eNOS coexpressed
with the gap junction plaques. Cx43 was found to be constitutively
nitrosylated in the MEJ, and denitrosylation induced by addi-
tion of phenylephrine resulted in a reduced movement of inositol
triphosphate from theVSMC to the EC via the MEJ gap junctions,
and this decreased gap junction permeability was associated with
an decreased nitrosylation of Cx43 at the Cys271 residue in the
intracellular C-terminal part of the protein (Straub et al., 2011).
Other data also support the notion that nitrosylation may play role
in modifying gap junctions in the vasculature. Two independent
studies show that NO donors decrease the permeability between
ECs toward small molecules and reduce the electrical coupling of
gap junctions composed of Cx37 (Kameritsch et al., 2005; McK-
innon et al., 2009). In both cases the effect was independent of
the action of NO on cGMP, but none of the studies provided any
direct evidence of changes in nitrosylationof the involvedproteins.
Taken together the studies suggest that nitrosylation of connex-
ins may play an important role in regulation of the intercellular
communication in the microcirculation. Intercellular communi-
cation is a prerequisite for conducted vasomotor responses, and
several conditions like hyperglycemia, hypertension and sepsis
is associated with changes in both vascular conduction and NO
production, however there is at present no information linking
these changes to changes in nitrosylation of the vascular connexins
(Gustafsson and Holstein-Rathlou, 1999; McKinnon et al., 2006,
2009; Rai et al., 2008; Rodrigo et al., 2011; Sudano et al., 2011).
Nitrosylation may also play a role in the regulation of
hemichannel function. Ischemia and/or hypoxia are associated
with an increased production of NO, and at the same time an
increase in Cx43 and Cx46 hemichannel permeability has been
observed (Retamal et al., 2006, 2009). The increased hemichan-
nel permeability leads to the loss of intracellular ions and small
organic compounds, which may contribute to cell death. Retamal
et al. (2006) showed that metabolic inhibition of cortical astro-
cytes resulted in an increased cell permeability as determined by
dye uptake. The increased dye uptake was associated with both
a dephosphorylation and a nitrosylation of the Cx43 hemichan-
nels. Addition of reducing agents, which decreases nitrosylation,
reduced the cellular permeability without having any effects on
the phosphorylation level. Since addition of external NO donors
also increases cell permeability in the same system, it was con-
cluded that S-nitrosylation play an important role in regulating
hemichannel permeability in astrocytes (Retamal et al., 2006). The
same group showed that addition of theNO-donorGSNO toCx46
hemichannels expressed in Xenopus oocytes caused an increased
voltage sensitivity and current amplitude (Retamal et al., 2009).
On the other hand, treatment of the cells by reducing agents
reversed the effect of GSNO on hemichannel currents, and muta-
tion of the two cysteine residues in the carboxy-terminal part of
Cx46 abolished the effect of GSNO.
METHYLATION AND ACETYLATION
Although methylation and acetylation are mainly known for their
epigenetic regulation of gene transcription by DNA methylation
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and histone acetylation, there is emerging evidence that connexins
may be directly modiﬁed. By mass spectrometry, Cx26 was shown
to be both methylated and acetylated (Locke et al., 2009). Five
methylated sites were detected, one of which (Arg75) is associated
with deafness causing mutations (R75W and R75Q), indicating
that methylation of this site plays an important physical role. Sev-
eral studies show that Cx26 channels carrying the R75W mutation
are dysfunctional, and although the channels are trafﬁcked to the
membrane, they do not result in electrical or metabolic coupling
(Richard et al., 1998; Marziano et al., 2003; Oshima et al., 2003;
Thomas et al., 2003b; Chen et al., 2005). The mutant channels
even had a dominant negative effect on not only wild type Cx26
(Richard et al., 1998; Marziano et al., 2003; Oshima et al., 2003)
but also on Cx30 (Forge et al., 2003; Marziano et al., 2003) with
which it coexpresses in the inner ear. Besides disrupting cell to cell
communication, mutation of Arg75 also reduced the permeabil-
ity and macroscopic conductance of Cx26 hemichannels, as well
as altered their voltage dependence (Chen et al., 2005; Deng et al.,
2006).
Besides methylation, Cx26 is also acetylated on six sites
including Lys15 and Lys102 for which disease causing muta-
tions/deletions are known (K15T, del102K; Locke et al., 2009).
Acetylation is also described in bovine Cx49 (ortholog of human
Cx50) on the N-terminal arginine, a commonly occurring mod-
iﬁcation (Shearer et al., 2008), which was also reported for Cx26
(Locke et al., 2009). An important physiological role for acetylation
was also reported for Cx43 in mdx mice, a model of Duchenne
muscle dystrophy (Colussi et al., 2011). Cx43 is acetylated and lat-
eralized in mdx mice and interference with acetylases/deacetylases
indicated causality between the two. Furthermore, mutagenesis
of three lysines (9, 234 and 264), predicted as acetylation targets,
showed that acetyl-mimeticmutations led to intracellular localiza-
tion, whereas Cx43 with un-acetylatable mutations were resistant
to acetylating conditions (Colussi et al., 2011).
The data from Cx26 and Cx43 clearly shows that methylation
and acetylation will likely emerge as important PTMs in the regu-
lation of intercellular communicationmediated by these and other
connexins.
GLUTAMATE γ-CARBOXYLATION
The conversion of glutamic acid to γ-carboxyglutamic acid is
a vitamin K dependent PTM, which was originally described
for blood clotting proteins (Nelsestuen et al., 1974; Stenﬂo et al.,
1974). The mass spectrometry study by Harris and Locke (2009)
identiﬁed glutamate γ-carboxylations in Glu42 and Glu47 in
the extracellular loop (E1), as well as Glu114 in the cytoplas-
mic loop of Cx26 (Locke et al., 2009). γ-carboxylation is an
irreversible modiﬁcation, which generates a high-afﬁnity Ca2+
binding site. This indicates that γ-carboxylation of Cx26 may
be involved in the regulation of Cx26 Ca2+ sensitivity and, in
this context, it is noteworthy that mutations at Glu42 and Glu47
cause Cx26 dependent deaf mutations (Lee and White, 2009).
This implies that glutamate γ-carboxylation of Cx26 may play
a physiological role and future studies may reveal if other Ca2+
sensitive connexins, such as Cx43 and Cx50, are also subject to
γ-carboxylation.
CONCLUSION
The literature clearly shows the importance of PTMs in mod-
ifying gap junctional coupling and dependent on the connexin
and the PTM type, may either increase or decrease intercellular
coupling. This is achieved by regulating connexin function at all
levels, including oligomerization, trafﬁcking, channel activity and
connexin degradation. The importance of these phenomena is
underpinned by the fact that several disease causing mutations
affect amino acids known to be PTM sites, as described above.
The large and increasing number of PTMs that regulate con-
nexins comprises a major challenge in unraveling their function
and importance. For instance, Cx43 contains at least 24 PTM
sites and the number of combinations thereof is overwhelming
and their investigation beyond the reach of current methods for
studying connexins. Most studies address only one or a few mod-
iﬁcations at a time using site directed phosphospeciﬁc antibodies
or mutagenesis. Such approaches carry the risk of overlooking
confounding inﬂuence of other modiﬁcations and may explain
some of the contradicting results in the literature. The ﬁeld of
proteomics is rapidly evolving and may eventually disclose quan-
titative important PTMs and combinations thereof occurring in
physiology and pathophysiology. At present, the published mass
spectrometry studies of connexins are limited to determinations of
whether a certain modiﬁcation is detectable or not. The threshold
for such detection is undeﬁned and not necessarily linked to the
threshold for achieving a signiﬁcant physiological effect although
this is often implied. In some cases, such as for Ser306 in Cx43,
one may ﬁnd a change in phosphorylation that passes the thresh-
old for detection after some intervention, in this case ischemia
(Axelsen et al., 2006), and be lucky enough that site phosphoryla-
tion is associated with a change in channel function (Procida et al.,
2009). The importance of other sites could pass undetected simply
because they did not pass threshold. Quantitative proteomics are
coming to our rescue and rapidly evolving (Cox and Mann, 2011),
but even these techniques may not reveal coupling of PTMs at the
single molecule level. In any case, the role of PTMs in regulating
intercellular communication, will keep researchers busy for years
to come.
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